In various malignancies, P300 and CBP can acetylate multiple lysine residues on p53, and acetylated p53 significantly enhances DNA binding ability and transcriptional activity, thereby promoting tumour cell cycle arrest, senescence and apoptosis (Table 1). The gene discussed is CREBBP; the disease is neoplasm.